Park Avenue Securities’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,717
Closed -$243K 1690
2025
Q2
$243K Buy
+5,717
New +$238K ﹤0.01% 1362
2025
Q1
Sell
-5,099
Closed -$280K 1516
2024
Q4
$280K Buy
+5,099
New +$258K ﹤0.01% 1308
2024
Q3
Sell
-4,923
Closed -$226K 1449
2024
Q2
$226K Sell
4,923
-119
-2% -$5.61K ﹤0.01% 1279
2024
Q1
$262K Buy
+5,042
New +$221K ﹤0.01% 1223

Other funds holding VCEL

Park Avenue Securities's VCEL Position: Q3 2025 in Review

Park Avenue Securities sold out of Vericel Corp (VCEL) in Q3 2025, closing a stake of 5,717 shares — an estimated $243K sold.

Park Avenue Securities first reported a position in VCEL in Q1 2024 and held it in 4 quarters. The position peaked at $280K in Q4 2024. 249 funds tracked by Wall St. Rank hold VCEL as of Q3 2025.

  • Park Avenue Securities reported no remaining Vericel Corp position as of Q3 2025 after selling out during the quarter.
  • Park Avenue Securities sold 5,717 Vericel Corp shares in Q3 2025, an estimated $243K.
  • Park Avenue Securities first reported a position in Vericel Corp in Q1 2024 and held it in 4 quarters.
  • Park Avenue Securities's Vericel Corp position peaked at $280K in Q4 2024.
  • 249 funds tracked by Wall St. Rank held Vericel Corp as of Q3 2025.

Based on Park Avenue Securities's 13F filing for Q3 2025, filed 23 Oct 2025.